Health
Metformin use reduces risk of death for patients with COVID-19 and diabetes – Medical Xpress
Use of the diabetes drug metformin—before a diagnosis of COVID-19—is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metforminbefore a diagnosis of COVID-19is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive Diabetes…
-
General5 hours agoFerries and celebrities as pollies dash to win the west
-
Noosa News24 hours agoState wants more punishment for teens who assaulted Wallaby great
-
Noosa News13 hours agoSpinach salads back on supermarket shelves amid E. coli probe
-
Business14 hours ago$10,000 invested in Telstra shares at Christmas is now worth